Anti-VEGFR, PDGFR, and CSF1R tyrosine kinase inhibitor CM082 (X-82) in combination with everolimus for treatment of metastatic renal cell carcinoma: a phase 1 clinical trial

Authors:
  • XYXieqiao Yan
    Xieqiao Yan
  • XSXinan Sheng
    Xinan Sheng
  • BTBixia Tang
    Bixia Tang
  • ZCZhihong Chi
    Zhihong Chi
  • CCChuanliang Cui
    Chuanliang Cui
  • LSLu Si
    Lu Si
  • LMLi Li Mao
    Li Li Mao
  • BLBin Lian
    Bin Lian
  • SLSiming Li
    Siming Li
  • LZLi Zhou
    Li Zhou
  • XWXuan Wang
    Xuan Wang
  • XBXue Bai
    Xue Bai

Abstract
No abstract available